Распространенность и профили антимикробной резистентности Salmonella spp. и Campylobacter spp., изолированных от людей с диареей и цыплят-бройлеров в Республикe Молдова by Halacu, Ala et al.
316
E P I D E M I O L O G I E
8. Сон И.М., Литвинов В.И., Стародубов В.П., Сельцов-
ский П.П. Эпидемиология туберкулеза. Москва, 
2003. 286 с. 
9. Яворский К., Чобану A., Болотникова B. и др. 
Aналитическая оценка заболеваемости туберку-
лезом и другими болезнями органов дыхания в 
период 2012-2014 гг. и реализация стратегии PAL 
в Pеспублике Mолдова. В: Вестник Смоленской 
Государственной медицинской академии, 2015, 
том 14, № 2. ISSN 2225-6016.
10. Яворский К.М., Болотникова В.А., Московчук А.Ф. и 
др. Туберкулез и другие бронхолегочные заболе-
вания: реалии сегодняшнего дня и перспективы 
развития фтизиопульмонологической помощи 
населению Республики Молдова. В: Туберкулез и 
болезни легких. Съезд фтизиатров России с между-
народным участием, 27-29 мая 2015 года. 2015, № 
5, c. 200-201. ISSN 2075-1230.
11. Global tuberculosis control: WHO report 2001. Geneva, 
2001. 
12. Global tuberculosis control: surveillance, planning, 
i nancing. WHO report 2005. Geneva, World Health 
Organization (WHO/HTM/TB/2005.349).  
13. Global tuberculosis report 2018. WHO. www.who.int/
tb/publications /global_report/en/
14. Rapoartele statistice F.2 Privind bolile infecțioase și 
parazitare, anii 1998-2018. 
15. Registre de evidență a bolilor infecțioase, f.060, anii 
1998–2018.
16. Fișa de anchetare epidemiologică a focarului de boală 
infecțioasă, f.357/e, anii 1998–2018.
Nicolai Gaisan, 
Centrul de Sănătate Publică Cahul, 
tel.: +373 299 3 30 64,
e-mail: nigaisan@gmail.com, 
              CZU: 616.98:578/.579:615.015.8(478)
PREVALENCE AND ANTIMICROBIAL RESISTANCE 
PROFILES OF SALMONELLA SPP. AND 
CAMPYLOBACTER SPP. IN HUMAN AND 
BROILER CHICKEN IN REPUBLIC OF MOLDOVA
Ala HALACU1, Olga BURDUNIUC1, 
Svetlana PRUDNICIONOC1, Eleonora DUPOUY2, 
Maria BIVOL1, Tatiana ILGUNOVA1, Olga COTET1,
1National Agency for Public Health, Moldova,
2Food and Agriculture Organization of the United Nations 
(FAO), Rome, Italy
Summary
Foodborne diseases represent a significant public health 
burden and important cause of morbidity and mortality, 
and a signii cant impediment to socioeconomic development 
worldwide. In same time, antimicrobial resistance (AMR) of 
the Salmonella spp. and Campylobacter spp. is an increasingly 
threat to global public health that requires action across all 
countries, government sectors and society, which is linked to 
irrational antimicrobial use in human sector and food ani-
mals. We aimed to get insight on the occurrence and AMR 
of Salmonella spp. and Campylobacter spp. isolated from hu-
mans with diarrhea and broiler chicken in Moldova, as such 
obtained results can evidence base and help national policy 
making   to make decisions and take necessary measures for 
reducing the spread of strains resistant to antimicrobial. 
Keywords: Salmonella spp., Campylobacter spp., antimicro-
bial resistance.
Rezumat
Prevalența și proi lurile de rezistență antimicrobiană ale 
Salmonella spp. și Campylobacter spp. izolate de la oameni 
și din carnea de pui în Republica Moldova
Bolile cu factor de transmitere alimentar reprezintă o povară 
importantă pentru sănătatea publică, constituie o cauză 
majoră a morbidității și mortalității și un impediment sem-
nii cativ pentru dezvoltarea socioeconomică la nivel mondial. 
În același timp, rezistența antimicrobiană (AMR) a speciilor 
Salmonella spp. și Campylobacter spp. este o amenințare din 
ce în ce mai mare pentru sănătatea publică la nivel global, care 
necesită acțiuni în toate țările, în sectoarele guvernamentale 
și în societate, amenințare rezultată din utilizarea irațională 
a antimicrobienelor în sectorul uman și în hrana animalelor. 
Ne-am propus să înțelegem apariția AMR a Salmonella spp. 
și Campylobacter spp. izolate de la oameni cu diaree și din 
carne de pui broiler din Moldova, astfel că rezultatele obținute 
pot deveni o bază pentru elaborarea politicilor naționale, prin 
care s-ar lua decizii și măsurile necesare pentru reducerea 
răspândirii tulpinilor rezistente la antimicrobiene.
Cuvinte-cheie: Salmonella spp., Campylobacter spp., 
rezistență la preparatele antimicrobiene
Резюме
Распространенность и профили антимикробной рези-
стентности Salmonella spp. и Campylobacter spp., изо-
лированных от людей с диареей и цыплят-бройлеров 
в Республикe Молдова
Болезни пищевого происхождения представляют собой 
серьезное бремя для общественного здравоохранения и 
являются важной причиной заболеваемости и смерт-
ности, а также значительным препятствием для 
социально-экономического развития во всем мире. В то 
же время устойчивость Salmonella spp. и Campylobacter 
spp. к противомикробным препаратам во всем мире ста-
новится все более серьезной угрозой для общественного 
здравоохранения, которая требует действий во всех 
странах, государственных секторах и обществе, что 
связано с нерациональным использованием противоми-
кробных препаратов в человеческом секторе и в кормах 
для животных. Мы стремились получить представле-
ние о происхождении устойчивости к противомикроб-
ным препаратам Salmonella spp. и Campylobacter spp., 
изолированных от людей с диареей и цыплят-бройлеров, 
так как полученные результаты могут послужить до-
казательной базой и помочь в разработке национальной 
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политики для принятия решений и необходимых мер для 
сокращения распространения штаммов, устойчивых к 
противомикробным препаратам.
Ключевые слова: Salmonella spp., Campylobacter spp., 
антимикробная резистентность
Introduction 
Foodborne diseases are globally important, as 
they result in considerable morbidity, mortality, and 
economic costs [1,2]. 
Campylobacteriosis and salmonellosis are the 
two most frequently reported food borne diseases 
worldwide and chicken meat is considered to be one 
of the most important food vehicles. The burden of 
the diseases and the cost of control measures are 
highly significant in many countries and contamina-
tion with zoonotic Campylobacter and Salmonella 
has the potential to severely disrupt trade between 
countries [3]. 
World Health Organization (WHO) estimates, 
that each year, almost 1 in 10 people fall ill and 33 
million of healthy life years are lost. According to 
WHO, diarrheal diseases are resulting from eating 
unsafe food, with 550 million people falling ill yearly 
(including 220 million children under the age of 5 
years) and Campylobacter is 1 of the 4 key global 
causes of them. The true incidence of gastroen-
teritis due to Campylobacter spp. is poorly known, 
particularly in Low- and Middle-income countries. 
Studies in high-income countries have estimated 
the annual incidence at between 4б4 and 9б3 per 
1000 population [4]. 
Nontyphoidal salmonellae are a leading cause 
of bacterial diarrhea worldwide; they are estimated 
to cause approximately 153 million cases of gas-
troenteritis and 57,000 deaths globally each year. 
Nontyphoidal salmonellosis refers to illnesses caused 
by all serotypes of Salmonella except for Typhi, Para-
typhi A, Paratyphi B, and Paratyphi C. Usually, people 
fall ill from through the consumption of food or 
water contaminated with animal feces. Transmission 
can also occur through direct contact with infected 
animals or their environment and directly between 
humans [5]. 
Antimicrobial resistance (AMR) is a major thre-
at to global health and the world economy, and 
poses a unique challenge to humanity. Resistant 
microorganisms exist in humans, animals, food, 
and the environment. This makes AMR a complex 
epidemiological issue. The main cause of AMR is 
antimicrobial use. A comprehensive, collaborative 
and coordinated collection and analysis of data from 
multiple domains. WHO, FAO, OIE and the OECD need 
to develop targets and goals to promote appropriate 
use of antimicrobials in human, animal and plant 
health to prevent infection. Application of improved 
hygiene standards along the food production chain, 
«from farm to fork», is of paramount importance to 
control the dissemination of all zoonotic foodborne 
pathogens, and thus the drug resistant ones [6]. 
The AMR Review calculated that resistant bacte-
ria already kill more than 700.000 people worldwide. 
This study has estimated the global economic cost 
of antimicrobial drug resistance by 2050. The results 
show a considerable human and economic cost. 
Initial research, looking only at part of the impact 
of AMR, shows that a continued rise in resistance by 
2050 would lead to 10 million people dying every 
year and a reduction of 2% to 3,5% [8]. 
A public health related monitoring system for 
antibiotic resistance is set up in Moldova, including 
the antimicrobial susceptibility testing for Salmo-
nella. The Technical Assessment conducted by the 
European Centre for Communicable Disease Control 
(ECDC) noted that level of disease recognition and 
reporting was critically low for some diseases, in-
cluding Campylobacter. No information is available 
on the occurrence of Campylobacter infection in 
Moldova, from humans. 
This study conducted a survey to obtain a pre-
liminary understanding of the occurrence and AMR 
of Salmonella and Campylobacter among human 
patients with diarrhea in Moldova, with the overall 
objective of informing policy-making on food safety 
and AMR in Moldova.
Materials and methods
Studies to evaluate the presence of Salmonella 
and Campylobacter microorganisms among humans 
and in poultry in Moldova and antimicrobial resis-
tance assessment was conducted during October- 
February 2018.
87 fecal samples were collected from the Mu-
nicipal Clinical Hospital for Contagious Disease for 
Children, from the patients with acute diarrhea (acu-
te enterocolitis, gastroenteritis, gastro-enterocolitis, 
hemocolitis, and food poisoning). Samples were col-
lected before initiating antimicrobial treatment and 
analyzed in the laboratory of extremely contagious 
acute diarrheal diseases and zooanthroponosis in 
compliance with the existing and accepted metho-
dology in the country [9]. 
In collaboration with the National Food Safety 
Agency, 75 samples of poultry meat were collected 
from 11 domestic producers (60 samples) and 4 im-
port manufacturers (15 samples). Samples of poultry 
meat have been taken from slaughterhouses and 
slaughter centers after the technological process, 
as well as from the warehouses of the finished pro-
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duct in compliance with the sampling requirements 
stipulated in normative documents. A study for the 
detection of Salmonella and Campylobacter in poul-
try meat was conducted in the Sanitary Microbiology 
Laboratory using standardized methods. All samples 
were coded by the seal and sent to the laboratory on 
the day of collection with the accompanying docu-
mentation. From total 75 investigated samples – 49 
samples (65,3%) were collected and sent for research 
on the day of production, 26 samples (34,7%) were 
sampled and shipped in the frozen state (from 3 
to 12 months from date of manufacture). Until the 
investigation, all samples were stored in the refri-
gerator at 2-8 °C, previously frozen samples were 
defrosting [13-16].
The preliminary biochemical identification of 
Salmonella spp. was performed using the Kligler 
medium (HiMedia, India) based on the possibility 
of isolated strains to ferment glucose and lactose 
and produce hydrogen sulfide and using O.B.I.S. 
Salmonella test (Oxoid, UK) for the differentiation 
of microorganisms with a similar appearance of 
colonies (Citrobacter spp., Proteus spp.). For the full 
biochemical identification, were used commercial 
biochemical tests API 20E (bioMerieux, France).
Salmonella isolates from poultry meat and hu-
mans were sera-identified according to the general 
recommendations for salmonella serotyping and 
the Kauffmann-White scheme using both poly- and 
monovalent salmonella serum (O and H sera).  
For the identification and differentiation of 
Campylobacter strains from humans, the following 
tests were performed: microscopy (Gram), mobility 
(Brucella broth, HiMedia), catalase, oxidase, sus-
ceptibility testing to nalidixic acid and cephalothin 
(cephazolin), sodium Hippurate hydrolysis test. The 
inoculated media were incubated for 24-48 hours 
to 41,5 ºC under microaerophilic and hypercapnia 
conditions. 
The tests specified in ISO [16] have been used 
for the confirmation of suspected colonies of Cam-
pylobacter spp. obtained from the poultry meat 
research: morphology (Gram microscopy), mobility 
(Brucella broth, HiMedia), possibility of microaerobic 
growth at 25 ºC and aerobic conditions at 41,5 ºC 
(Collagen Blood Agar, HiMedia) and presence of oxi-
dase. In addition, O.B.I.S. Campy test (Oxoid, UK) for 
gram-state screening and L-alanyl aminopeptidase 
(L-ALA) activity in order to differentiate microorga-
nisms from Campylobacteraceae from other micro-
organisms with similar morphology.
The antimicrobial susceptibility of Campy-
lobacter and Salmonella isolates were tested in 
accordance with the EUCAST methodology [19] 
using the disc-diffusion method commercial discs 
(HiMedia, India).
Salmonella isolates have been tested in 19 
antimicrobial agents, which are part of 7 classes of 
antimicrobial group: Penicillin’s (Ampicillin 10 μg, 
Piperacillin 30 μg, Amoxiclav 30 μg); Cephalosporins 
(Cefotaxime 5 μg, Cefoxitin 30 μg, Ceftazidime 10 μg, 
Cefepime 30 μg); Carbapenems (Ertapenem 10 μg, 
Meropenem 10 μg); Fluoroquinolones (Ciprofloxacin 
5 μg, Norfloxacin 10 μg, Ofloxacin 5 μg,  Levofloxacin 
5 μg); Aminoglycosides (Gentamicin 10 μg, Amikacin 
30 μg, Tobramycin 10 μg, Netilmicin 10 μg); Amphe-
nicols (Chloramphenicol 30 μg) and Sulfanilamide 
(Co-Trimoxazole 25 μg). The quality control of the 
sensitivity assessment procedure was assured by the 
Escherichia coli ATCC 25922 microorganism test.
The antimicrobial susceptibility of Campylo-
bacter isolates was tested using the disc-diffusion 
method [19] with commercial discs (HiMedia, 
India) containing erythromycin (15 μg disc load), 
tetracycline (30 μg disc load), and ciprofloxacin (5 
μg disc load), as per the protocol of the European 
Committee on Antimicrobial Susceptibility Testing 
(EUCAST) [19]. 
We used Campylobacter coli ATCC 33559, Cam-
pylobacter jejuni ATCC 33291 for quality control. 
Results and discussion
Isolation of Salmonella and Campylobacter 
from human patients 
Of the 87 human samples, 9 (10,4%) were po-
sitive for Salmonella spp. The following Salmonella 
serovars have been identified: 5 serovars from group 
O:9 (D1) (Salmonella Enteritidis) and 4 serovars from 
group O:4 (B) (Salmonella Typhimurium) and 7 (8,0%) 
for Campylobacter spp. (3 strains of Campylobacter 
coli and 4 strains of Campylobacter jejuni). The results 
are presented in Table 1. Positive for both Salmonella 
spp. and Campylobacter spp. not were detected 
none of the samples. 
Following the study of 75 samples of poultry 
analyzed in 6 samples (8%), Salmonella was detec-
ted, including: 3 salmonella (17,6%) was found from 
chicken carcasses, 1 salmonella from chicken meat 
(8,3%), chicken neck (10%) and chicken caecum with 
content (2%). In 5 cases, Salmonella was detected 
from fresh samples and in one case from the frozen 
sample with a longer shelf-life. Campylobacter sus-
pect colonies were not confirmed by the tests used 
and therefore Campylobacter was not detected from 
the poultry samples tested in this study. The results 
are presented in Table 2. The following Salmonella 
serovars have been identified: 2 serovars from gr. O:7 
(S. Othmarschen, S. Isangi), 2 serovars from gr. O:4 
(S. Lagos, S. Pasing) and 2 strains of S. Serftenberg (gr. 
0:3,19) and correlate with the multiannual monito-
ring data on the circulation of Salmonella serotypes 
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in the environment and food on the territory of Mol-
dova (S. Othmarschen, S. Lagos and S. Senftenberg 
are sporadically recorded). For the first time, S. Isangi 
serotypes (frozen chicken carcass) and S. Pasing 
(chicken caecum with content) were identified. 
Antimicrobial susceptibility testing of Sal-
monella isolates
Table 3 presents the summary results of anti-
microbial susceptibility testing of the 9 Salmonella 
isolates from human patients and 6 Salmonella 
isolates from poultry. In total, 88,8% of isolates from 
humans were resistant to amoxiclav, 77,7% to am-
picillin, 66,6% to cefoxitin, 55,5% to piperacillin and 
55,5% to ceftazidime. Of these isolates, 100% were 
susceptible to netilmicin and none was resistant and 
intermediate susceptible; 88,8% were susceptible 
to cefotaxime, 88,8% to gentamicin and 88,8% to 
chloramphenicol.
In total, 50% of Salmonella isolated from poultry 
meat were resistant to ampicillin, 50% to cefepime, 
33,3% to amoxiclav, 16,6% to ceftazidime and 16,6% 
to ciprofloxacin. All isolates were susceptible to ce-
fotaxime, cefoxitin, levofloxacin, norfloxacin, to all 
antimicrobial preparations tested in the aminoglyco-
side class, ampicillin and sulfanilamide. Intermediate 
sensitivity to piperacillin (33,3%), cefepime, ceftazi-
dime and ofloxacin (16,6%) was observed.
Table 3 provides an overview of the AMR profiles 
and the frequencies observed for the Salmonella 
isolates from humans and from poultry. 
None of the Salmonella isolated from humans 
were sensitive to all antimicrobials included in the 
susceptibility testing. All Salmonella isolated were 
resistant to at least one antimicrobial agent. Of 
the Salmonella isolates from human, 22.2 % were 
resistant to one class of antimicrobial agents. One 
isolated of Salmonella was resistant to 2 classes, 4 
classes and 5 classes of antimicrobial agents. 
Of the 6 strains of Salmonella isolated from 
poultry meat, only 1 strain (16,6%) demonstrated 
sensitivity to all antimicrobial preparations used in 
the study. Strains resistant to all antimicrobial agents 
have not been detected. Of the Salmonella isolated 
from poultry meat 33,3% were resistant to only one 
antimicrobial preparation, 33,3% were resistant to 
1 class of antimicrobial preparations and 50% were 
resistant to 2 classes of antimicrobial preparations. 
In this study, strains of Salmonella isolated from 
poultry have not demonstrated resistance to three 
and more classes of antimicrobial preparations 
concomitantly.
Summary results of the antimicrobial suscep-
tibility testing of the Campylobacter isolates are 
presented in Table 4. 
Table 5 provides an overview of the AMR profiles 
and the frequencies observed for the Campylobac-
ter isolates from humans. All isolates from humans 
were resistant to at least one antimicrobial class. In 
result none Campylobacter isolated from humans 
were resistant to all three antimicrobial classes, i.e. 
multi-resistant (Table 6). The results of this study 
confirm that Salmonella and Campylobacter are 
etiologically significant factors of clinical diarrheal 
diseases among the population of Moldova, which 
is in line with data from several studies conducted 
in different countries Analysis of the results shows 
that meat products and their semi-finished products 
can be a source of human infection, 8% of the tested 
samples have been infected with Salmonella.
The Food-borne Diseases Active Surveillance 
Network (FoodNet) of the United States Centers 
for Disease Control and Prevention reported that 
incidence of Salmonella infection was highest 
among the total food poisoning cases (CDC, 2010). 
Especially, Salmonella enterica serovars Enteritidis 
and Typhimurium are the most frequently identified 
bacteria in human salmonellosis (Chung et al., 2003; 
Cheong et al., 2007). The results of the multi-annual 
monitoring carried out in Moldova correlate with 
the published data of the prevalent Salmonella 
serovars. Annually, the share of S. Enteritidis in food 
and other environmental objects is from 28% to 82%, 
S. Typhimurium from 2% to 45% (annual national 
report, National Center of Public Health) and in most 
cases detected in research into food poisoning. The 
results of our survey confirm that Salmonella spp. 
and Campylobacter spp. are important etiological 
agents of clinical diarrheal disease among humans 
in Moldova.
In this study from humans were isolated only 
two serotypes, Salmonella Typhimurium and Salmo-
nella Enteritidis. The Salmonella Typhimurium and 
Salmonella Enteritidis serovars represent 98,6% of the 
serological structure of Salmonella spp. in humans 
(2014 – 95,6%, 2015 – 93,2%, 2016 – 95,7%). But, ac-
cording to the annual epidemiological surveillance 
data of the acute diarrheal diseases in 2017 were re-
gistered significant changes in the etiological struc-
ture of salmonellosis in the human population. The 
intense migration of the population, the import of 
food condition the circulation of unusual serotypes 
such as: S. Agona, S. Derby, S. Kingston, S. Montevideo, 
S. Kentucky, S. Nchanga. The results indicate that in 
the onset of salmonellosis in Moldova an important 
role may represent broiler chicken, as in many other 
countries [20, 21]. 
Salmonella serovars found in this study (S. Oth-
marschen, S. Lagos and S. Senftenberg are sporadically 
recorded) correlate with the multiannual monitoring 
data on the circulation of Salmonella serotypes in the 
environment and food on the territory of R. Moldova. 
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The prevalent serotypes of Salmonella (S. Enteritidis, 
S. Typhimurium) were not detected, conditioned by 
several factors, which require a more detailed study. 
From year to year the range of isolated salmonella in 
the republic are filled with new serovars. In this stu-
dy, new serotypes for Moldova were also identified: 
S. Isangi and S. Pasing. 
The variety of isolated strains of salmonella 
complicates the task of the veterinary service to de-
tect and eliminate sources of infected products in the 
country’s trade network, and poses the task of public 
health monitoring for the regular monitoring of the 
circulation of pathogenic strains of ADD in humans 
and their sensitivity to antibiotics. 
According to published data [22], the prevalen-
ce of Campylobacter in chicken in European coun-
tries is from 11-12% (Finland, Denmark) to 70-76% 
(Spain, Austria, France).
Conducted study, contributed to implemen-
tation for the first time in the country the microbi-
ological method of isolation and identification of 
Campylobacter spp. Thus, at patients with acute 
diarrheal diseases included in the study were detec-
ted 7 strains of Campylobacter spp. with prevalence 
of Campylobacter jejuni. 
Campylobacter was not detected from the po-
ultry samples tested in this study. Actually, national 
legislation does not provide for the determination of 
Campylobacter in poultry [23], but at the same time 
ISO standards are approved as national standards 
for Campylobacter detection by both the detection 
method and the counting method [16].
This study was a first step in the approval and 
implementation of the method of detection of 
Campylobacter in poultry meat. The study revealed 
some gaps that need to be evaluated and considered 
in organizing the laboratory test in the presence of 
Campylobacter namely: the impact of the season 
study/investigation, the place of sampling, the 
state of the collected samples, the sampling pro-
cess/scheme, etc. The sampling period which held 
during October – February 2018 (which is not the 
main season of acute bacterial intestinal infections 
among humans in Moldova), and not the summer 
and early autumn when usually most cases of salmo-
nellosis and campylobacteriosis are reported so we 
can conclude that the real burden of salmonellosis 
and campylobacteriosis in the human population 
is higher.
Data from the literature highlights that one of 
the best predictors of Campylobacter prevalence is 
the season, the highest prevalence observed in June 
[22, 25], other factors related to broiler growth, such 
as growth practices, biosecurity or bird health, may 
be important [26].
There are different data on Campylobacter sur-
vival in frozen conditions. According to the literature 
[28, 29] some studies show that differences in the 
prevalence of C. jejuni in fresh and frozen samples 
is a strong indicator that freezing or frozen storage 
is detrimental to C. jejuni survival and subsequent 
isolation in the laboratory. Freezing may reduce the 
number of live campylobacter and chicken mus-
hrooms (Garenaux et al., 2009; Sampers et al., 2010) 
and that usually freezing chicken or skin for 24 hours 
causes a reduction in the number of campylobacter 
(Oyarzabal et al., 2010; Sampers et al., 2010). Howe-
ver, other studies [30] show that no difference in the 
recovery of C. jejuni from fresh, chilled or frozen sam-
ples after selective enrichment has been detected, 
showing that this microorganism can survive under 
the storage conditions tested.
Among the polyetiological group of intestinal 
diseases, diseases caused by resistant bacteria, who-
se occurrence is provoked by the use of antibiotics 
in agriculture and the use of livestock products, 
become more and more dangerous these days. 
Prevention, detection and medical care for the 
emergence of diseases caused by resistant strains of 
microorganisms require a comprehensive approach, 
including cooperation and information support 
between public health and the veterinary service. 
To control the occurrence, spread and circulation 
of antibiotic-resistant strains, monitoring of the use 
of antimicrobial agents in livestock production is 
necessary. The World Health Assembly of 2015 called 
upon all states to develop by 2017 individual action 
plans to combat the emergence of resistant strains 
of microorganisms.
Based on the veterinary service within Nati-
onal Agency for Food Safety date antimicrobials 
are routinely used in poultry production and are 
also available without a veterinary prescription. 
The antimicrobial classes most commonly used are 
tetracyclines, aminoglycosides, fluoroquinolones 
and Penicillin’s. These classes of antimicrobials are 
considered critically important because are also 
used in the treatment of human pathologies. FBD 
caused by resistant bacteria are well documented 
in humans, and can be linked with antimicrobial use 
in food animals.
According to the EFSA data antimicrobials 
such as ampicillin, sulfonamides and tetracyclines 
have been widely used for many years in veterinary 
medicine to treat infections in production animals. 
Generally, moderate to high levels of resistance 
to these antimicrobials are reported by European 
countries from producing animals and meat pro-
ducts thereof. 
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Despite the limited number of patients (i.e. only 
87) and poultry meat (i.e. only 75), tested strains on 
antimicrobial susceptibility does not permit to draw 
some accurate conclusions about the resistance to 
these preparations tested. 
Thereby, in the study Salmonella isolates from 
humans presented resistance to more classes of 
antimicrobials (to two classes and four classes), this 
can lead to deficiencies in the treatment of these 
infections especially invasive cases of salmonellosis. 
Most Campylobacter spp. isolates from humans were 
resistant to two classes antimicrobial which indicates 
the importance of the antimicrobial susceptibility 
testing for prescribing appropriate therapy and 
avoiding therapeutic failure. 
Data obtained from the study of the resistance 
of Salmonella strains detected in poultry to anti-
microbial preparations shows the high-moderate 
resistance to ampicillin (50%) and the low resistance 
(16,6%) to ciprofloxacin and correlates with the data 
published by EFSA. Of all 6 strains of Salmonella 
isolated from poultry meat, only 1 strain (16,6%) 
demonstrated sensitivity to all antimicrobial prepa-
rations used in the study.
Strains resistant to all antimicrobial agents have 
not been determined. Of Salmonella isolated from 
poultry meat, 2 strains (33,3%) were resistant to one 
class of antimicrobial preparations and 3 strains 
(50%) were resistant to 2 classes of antimicrobial pre-
parations. In this study strains of Salmonella isolated 
from poultry meat have not demonstrated resistance 
to three and more classes of antimicrobial prepara-
tions concurrently. The data obtained demonstrates 
the actuality of the study and the need for further 
study of antimicrobial resistance in zoonotic and 
indicator bacteria from humans and food.
Conclusion
1. The study is a first step in studying the 
prevalence of Salmonella spp. and Campylobacter 
spp. in poultry in Republic of Moldova, including 
antimicrobial susceptibility testing, and is the reason 
to discuss the need to organize deeper studies with 
the application of the provisions of the relevant 
documents.
2. The study has shown the existence of the 
problem in the field of food chain safety from a mi-
crobiological point of view and the need to intensify 
the mutual cooperation of stakeholders (such as 
ANSA and ANSP) on the monitoring of Salmonella 
and Campylobacter circulation in the food chain and 
the environment and impact assessment on public 
health. 
3. The burden of foodborne diseases in our 
country, re-emergence of antibiotic-resistant food-
borne bacteria requires concerted efforts in terms of 
collaboration, funding, awareness and commitment 
from government, and policy makers,
4. Harmonization of national legislation on 
the monitoring of zoonoses and zoonotic agents 
and microbiological criteria for foodstuffs to the 
requirements of European directives.
5. The method of detection and counting of 
Campylobacter spp. and the Salmonella counting 
method have to be implemented in Laboratories at 
national (ANSP, ANSA) and territorial (CPH) level and 
clinical laboratories.
Table 1
Type and number of samples and the frequency of isolation of Salmonella and Campylobacter
Sample (n=87)
Salmonella positive 
(n=9)
Campylobacter positive
 (n=7)
Human, faeces from patients 
with diarrhea 
S. Enteritidis S. Tiphymurium C. jejuni C. coli
no % no % no % no %
5 5,7 4 4,5 4 4,5 3 3,7
Table 2
Type and number of samples and the frequency of isolation of Salmonella and Campylobacter from poultry
Sample type
Samples tested Salmonella positive Campylobacter positive
n n % n %
Poultry, carcasses, 
chicken and turkey 
meat, neck and 
offal of chickens, 
intestinal content 
(caecum)
75 6 8,0 - -
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Table 3
Antimicrobial susceptibility of Salmonella spp. isolates from humans and from poultry
Antimicro bial
Isolates from humans (n=9) Isolates from poultry (n=6)
R I S R I S
n % n % n % n % n % n %
Penicillin’s:
ampicillin 7 77.7 0 0 2 22.2 3 50 0 0 3 50
piperacillin 5 55.5 2 22.2 2 22.2 0 0 2 33.3 4 66.6
amoxiclav 8 88.8 0 0 1 11.1 2 33.3 0 0 4 66.6
Cephalosporins:
cefotaxime 1 11.1 0 0 8 88.8 0 0 0 0 6 100
cefepime 3 33.3 4 44.4 2 22.2 3 50 1 16.6 2 33.3
ceftazidime 5 55.5 2 22.2 2 22.2 1 16.6 1 16.6 4 66.6
cefoxitin 6 66.6 1 11.1 2 22.2 0 0 0 0 6 100
Quinolones:
ciprofloxacin 2 22.2 1 11.1 6 66.6 1 16.6 0 0 5 83.3
levofloxacin 1 11.1 3 33.3 3 33.3 0 0 0 0 6 100
norfloxacin 3 33.3 2 22.2 4 44.4 0 0 0 0 6 100
ofloxacin 1 11.1 3 33.3 3 33.3 0 0 1 16.6 5 83.3
Aminoglyco sides:
gentamicin 0 0 1 11.1 8 88.8 0 0 0 0 6 100
amikacin 0 0 4 44.4 5 55.5 0 0 0 0 6 100
tobramycin 1 11.1 1 11.1 7 777 0 0 0 0 6 100
netilmicin 0 0 0 0 9 100 0 0 0 0 6 100
Amphenicols:
chloramphenicol 1 11.1 0 0 8 88.8 0 0 0 0 6 100
Carbapenems:
meropenem 1 11.1 1 11.1 7 77.7 0 0 0 0 6 100
ertapenem 2 22,2 3 33,3 4 44,4 0 0 0 0 6 100
Note. I – intermediate susceptible; R – resistant; S – susceptible. 
Table 4 
Resistance profiles of Salmonella isolates from humans and from poultry
AMR profile
Isolates from humans (N=9) Isolates from poultry (N=6)
n % n %
Susceptible to all antimicrobial agents 0 0 1 1,66
Resistant to all antimicrobial agents 0 0 0 0
Resistant to at least one antimicrobial agent 9 100 2 33,3
Resistant to one class of antimicrobial agents  Penicillin’s 
(AP/AUG/PTZ)
2 22,2 2 33,3
Ampicilin (AP) 7 77,7 1 16,6
Amoxiclav (AUG) 8 88,8 1 16,6
Piperacilin (PTZ) 5 55,5
Resistant to two classes of antimicrobial agents 1 11,1 3 5,0
Penicillin’s (AP/AUG/PTZ) /Quinolones (CIP/LEV/NOR) 1 11,1
Ampicillin (AP)/cefepime (CPM) 3 33,3 1 16,6
Ampicillin (AP)/amoxiclav (AUG)/cefepime (CPM)/ceftazidime (CAZ) 3 33,3 1 16,6
Cefepime (CPM)/ciprofloxacin (CIP) 1 11,1 1 16,6
Resistant to three classes of antimicrobial agents 0 0 0 0
Resistant to four classes of antimicrobial agents 1 11,1 0 0
Penicillin’s (AP/AUG/PTZ) / Cephalosporins (CTX/CPM/CAZ/FOX) / 
Carbapenems (MEM/IMI), Amphenicols (C) 1 11,1
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Table 5
Antimicrobial susceptibility of Campylobacter spp. isolates from humans
Antimicrobial agent
Isolates from humans (N=7)
R I S
n % n % n %
Macrolides: erythromycin 5 71.4 0 0 2 28.5
Tetracyclines: tetracycline 3 42.8 0 0 4 57.1
Quinolones: ciprofloxacin 4 57.1 1 14.2 2 28.5
Table 6
Resistance profiles for Campylobacter spp. isolates from humans
AMR profile
Campylobacter isolates from humans (N=7)
n %
Susceptible to all antimicrobial agents 0 0
Resistant to at least one antimicrobial agent 7 100
Resistant to one class of antimicrobial agents:
Tetracyclines (TE)
Macrolides (E)
2
1
1
28.5
14.2
14.2
Resistant to two classes of antimicrobial agents:
Tetracyclines (TE)/Quinolones (CIP)
Macrolides (E)/Quinolones (CIP)
Macrolides (E)/Tetracyclines (TE)
5
1
3
1
71.4
14.2
42.8
14.2
Resistant to three or more classes of antimicrobial agents 0 0
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PROBLEMELE-CHEIE ALE SITUAȚIEI 
EPIDEMIOLOGICE NEFAVORABILE ÎN 
LOCALITĂȚILE RURALE CU PRIORITATE PENTRU 
TUBERCULOZĂ DIN REPUBLICA MOLDOVA
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Rezumat
În poi da realizărilor medicinei contemporane, tuberculoza 
(TB) continuă să prezinte un mare pericol. Scopul studiului 
efectuat a fost depistarea particularităților situației epidemi-
ologice și cercetarea componenței contingentului bolnavilor 
din satele cu situația nefavorabilă privind TB. Obiectul de 
studiu l-au constituit 26 de localități din raioanele Ialoveni, 
Nisporeni, Strășeni, Comrat și cohorta bolnavilor cu TB pul-
monară primar depistați. Au fost demonstrate importanța 
studierii particularităților situației epidemiologice și rolul 
determinant al parametrilor de bază sociodemografici, 
care caracterizează componența cohortei. A fost accentuată 
necesitatea întăririi relațiilor dintre serviciul general și cel 
specializat, atragerii organizațiilor neguvernamentale. Rezul-
tatele obținute și concluziile formulate pot i  folosite înpentru 
optimizarea programelor în lupta cu TB la nivelul raionului 
și al comunității.
Cuvinte-cheie: localități rurale, tuberculoză pulmonară, 
situație epidemiologică, acordarea ajutorului medical
Summary
h e key problems of clinical and epidemiological issues in 
rural areas of high priority for tuberculosis in the Republic 
of Moldova
Despite the advances of the modern medicine, tuberculosis 
(TBC), as a dangerous infectious disease, still remains a 
serious threat. h e purpose of the study was to identify the 
peculiarities of the epidemiological situation and the con-
tingent of patients from the villages with a TB high-risk 
population. h e study was conducted in 26 settlements from 
Ialoveni, Nisporeni, Straseni, Comrat districts and the cohort 
(173) of newly diagnosed patients with pulmonary TB. It is 
shown the importance of studying the characteristics of the 
epidemiological situation and the determining role of the main 
clinical, socio-demographic parameters that denote the cohort 
composition. It is underlined the necessity to strengthen the 
interaction of specialized and general medical services, the 
involvement of non-governmental organizations. h e obtained 
results of TB control at the district and local levels. 
Keywords: rural communities, pulmonary tuberculosis, epi-
demiological situation, medical assistance
Резюме
Ключевые проблемы клинико-эпидемиологического 
неблагополучия в сельских населенных пунктах 
высокого приоритета по туберкулезу в Республике 
Молдова
Несмотря на достижения современной медицины, 
туберкулез (ТБ), являясь опасным инфекционным за-
болеванием, по-прежнему представляет серьёзную 
угрозу. Целью исследования было выявить особенности 
эпидемиологической ситуации и состава контингента 
больных в неблагополучных по ТБ селах. Объектом ис-
следования были 26 населенных пункта из Яловенского, 
Ниспоренского, Страшенского, Комратского районов и 
когорта (173) впервые выявленных больных ТБ легких. 
Показана значимость изучения особенностей эпиде-
миологической ситуации и детерминирующей роли 
основных клинических, социально-демографических 
параметров, характеризующих состав когорты. Сделан 
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